Impact of Novo Nordisk and Ozempic on Denmark's Economy

Denmark's economy is heavily reliant on the diabetes drug Ozempic, manufactured by Novo Nordisk, which has led to significant economic growth but also poses risks of imbalance and dependency on one company. Analogies are drawn to 'Dutch disease' and the 'Nokia trap' to caution against potential economic downturns if Novo Nordisk's fortunes change.

Biden Administration's Threat to Use 'March-In Rights' on Prescription Drugs

The Biden administration is threatening to use 'march-in rights' to increase government control over prescription drugs, which could impact innovation in the pharmaceutical industry. Critics argue that this move is more about expanding government power than helping consumers with affordable medical expenses.